产品中心 药物靶点和Fc受体 药物靶点

所有图片(1/4)

IL-23 R Fc Chimera Protein, Human

IBD17,IL-23 receptor

价格 1,460.00 供应商现货 : 3-5个工作日
货号 UA016005
规格
数量
收藏 分享

产品介绍 评论(0)

产品规格
  • 物种

    Human
  • 分子别名

    IBD17,IL-23 receptor
  • Accession

    Q5VWK5-1
  • 表达序列

    Gly24-Gly355 with hIgG1 Fc at the C-Terminus

  • 表达宿主

    HEK293
  • 分子量

    90-110kDa (Reducing)

  • 纯度

    >95% by SDS-PAGE & HPLC
  • 活性

    1.Immobilized Human IL-23 alpha & IL-12 beta Heterodimer Protein, No tag&His tag (Cat. No. S0A4041) at 1.0μg/mL (100μL/well) can bind IL-23 R Fc Chimera Protein, Human (Cat. No. UA016005) with EC50 of 20.7-29.4ng/mL. 2.IL-23 R Fc Chimera Protein, Human (Cat. No. UA016005) captured on Protein A Chip can bind Human IL-23 alpha & IL-12 beta Heterodimer Protein, No tag&His tag(Cat. No. S0A4041) with an affinity constant of 17.56 nM as determined in a SPR assay .
  • 标记

    Unconjugated
  • 标签

    Human IgG1 Fc
  • 性状

    Lyophilized Powder
  • 缓冲体系

    PBS, PH7.4, 5% trehalose

  • 溶解方法

    Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.

  • 储存条件

    · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃.
    · 3 months, -20 to -80℃ under sterile conditions after reconstitution.
    · 1 week, 2 to 8℃ under sterile conditions after reconstitution.
    · Please avoid repeated freeze-thaw cycles.

  • 文献引用

    1.Benson JM, Sachs CW, Treacy G, Zhou H, Pendley CE, Brodmerkel CM, Shankar G, Mascelli MA. Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab. Nat Biotechnol. 2011 Jul;29(7):615-24.
    2.Hue S, Ahern P, Buonocore S, Kullberg MC, Cua DJ, McKenzie BS, Powrie F, Maloy KJ. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006 Oct 30;203(11):2473-83.

背景介绍
  • Interleukin-23 (IL-23) is a heterodimeric cytokine composed of p19 and p40 subunits. Its functional receptor, IL-23R, combines with the IL-12Rβ1 subunit to form a type I cytokine receptor complex. This complex activates the downstream JAK2-STAT3 signaling pathway, regulating the proliferation, differentiation, and secretion of inflammatory factors in immune cells such as T cells and NK cells. It plays a central role in sustaining Th17 cell-mediated inflammatory responses. Clinically, abnormal activation of the IL-23/IL-23R pathway is a key pathogenic mechanism in autoimmune diseases such as psoriasis and inflammatory bowel disease. Additionally, it promotes tumorigenesis within the tumor microenvironment, making it a critical therapeutic target.
  • 电泳

    • 2μg (R: reducing condition, N:non-reducing condition).

  • 体积排阻色谱(SEC-HPLC)

    • The purity of IL-23 R Fc Chimera Protein, Human is more than 95% determined by SEC-HPLC.

  • ELISA

    • Immobilized Human IL-23 alpha & IL-12 beta Heterodimer Protein, No tag&His tag (Cat. No. S0A4041) at 1.0μg/mL (100μL/well) can bind IL-23 R Fc Chimera Protein, Human (Cat. No. UA016005) with EC50 of 20.7-29.4ng/mL.

  • SPR

    • IL-23 R Fc Chimera Protein, Human (Cat. No. UA016005) captured on Protein A Chip can bind Human IL-23 alpha & IL-12 beta Heterodimer Protein, No tag&His tag(Cat. No. S0A4041) with an affinity constant of 17.56 nM as determined in a SPR assay .

评论(0)